Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Non Operating Income (2024 - 2026)

Updated

Analysis

Evommune (EVMN) Non Operating Income (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Evommune 285.17 Mn -352.34 Mn - 2.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.65 Mn
Mar 31, 2026 2.28 Mn
Dec 31, 2025 1.44 Mn
Sep 30, 2025 853,000.00
Jun 30, 2025 9.43 Mn
Mar 31, 2025 475,000.00
Dec 31, 2024 728,000.00
Sep 30, 2024 601,000.00
API Access

Evommune Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=EVMN&period=max&api_key=YOUR_API_KEY